HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chunghyuldan activates NOS mRNA expression and suppresses VCAM-1 mRNA expression in human endothelial cells.

Abstract
Chunghyuldan (CHD), a combinatorial drug that has antihyperlipidemic and anti-inflammatory activities, has been shown to improve arterial stiffness and inhibit stroke recurrence in clinical study. To understand the molecular basis of CHD's clinical effects, we explored its effect on cell proliferation and expression of nitric oxide synthase (NOS) and vascular cell adhesion molecule (VCAM-1) in human umbilical vein endothelial cells (HUVECs). Cell number counting and [3H]thymidine incorporation assay demonstrated that nontoxic doses of CHD have an inhibitory effect on DNA synthesis and suppress cell cycle progression of HUVECs. CHD treatment led to a marked induction of NO production through up-regulation of NOS mRNA expression in a dose- and time-dependent manner, whereas it suppressed VCAM-1 expression. CHD inhibition of VCAM-1 expression was totally blocked by pretreatment with the NO synthesis inhibitor L-NMMA, whereas pretreatment with the NO donor DETA-NO further decreased VCAM-1 level in CHD-treated HUVECs, indicating that VCAM-1 regulation by CHD is mediated through increased NO synthesis by CHD. In addition, TNF-alpha-mediated VCAM-1 activation was substantially impeded by CHD treatment. Collectively, our data suggest that anti-inflammatory or anti-hyperlipidemic effects of CHD might be associated with its ability to activate NO production and suppress VCAM-1 expression in human endothelial cells.
AuthorsSeong-Uk Park, Woo-Sang Jung, Sang-Kwan Moon, Chang-Nam Ko, Ki-Ho Cho, Young-Suk Kim, Hyung-Sup Bae, Sung-Gil Chi
JournalCanadian journal of physiology and pharmacology (Can J Physiol Pharmacol) Vol. 83 Issue 12 Pg. 1101-8 (Dec 2005) ISSN: 0008-4212 [Print] Canada
PMID16462909 (Publication Type: Journal Article)
Chemical References
  • 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene
  • Chunghyuldan
  • DNA, Complementary
  • Drugs, Chinese Herbal
  • Enzyme Inhibitors
  • Nitrites
  • RNA, Messenger
  • Tetrazolium Salts
  • Thiazoles
  • Triazenes
  • Tumor Necrosis Factor-alpha
  • Vascular Cell Adhesion Molecule-1
  • omega-N-Methylarginine
  • Nitric Oxide
  • Nitric Oxide Synthase Type III
  • thiazolyl blue
  • Thymidine
Topics
  • DNA, Complementary (biosynthesis, genetics)
  • Drugs, Chinese Herbal (pharmacology)
  • Endothelial Cells (drug effects, metabolism)
  • Enzyme Induction (drug effects)
  • Enzyme Inhibitors (pharmacology)
  • Flow Cytometry
  • Humans
  • Nitric Oxide (biosynthesis)
  • Nitric Oxide Synthase Type III (antagonists & inhibitors, biosynthesis)
  • Nitrites (metabolism)
  • RNA, Messenger (biosynthesis)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tetrazolium Salts
  • Thiazoles
  • Thymidine (metabolism)
  • Triazenes (pharmacology)
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors, physiology)
  • Vascular Cell Adhesion Molecule-1 (biosynthesis)
  • omega-N-Methylarginine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: